April 26, 2023 03:01 PM EDTUpdated April 27, 07:52 AM
Pharma
Manufacturing

Bris­tol My­ers snaps up for­mer No­var­tis man­u­fac­tur­ing site in Illi­nois

Tyler Patchen

News Reporter

Bris­tol My­ers Squibb plans to take over a No­var­tis plant in a Chica­go sub­urb to man­u­fac­ture its CAR-T ther­a­pies.

The com­pa­ny said

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

A service from the Financial Times